🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 17 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/02/2010 | 35,02 | 35,36 | 34,77 | 35,19 | +0,85% | 1,69% | 13.800.483 |
| 25/02/2010 | 34,77 | 34,98 | 34,40 | 34,90 | -0,97% | 1,67% | 17.854.252 |
| 24/02/2010 | 35,02 | 35,34 | 34,61 | 35,24 | +1,15% | 2,10% | 17.913.988 |
| 23/02/2010 | 35,21 | 35,44 | 34,73 | 34,84 | -1,64% | 2,01% | 16.699.670 |
| 22/02/2010 | 36,13 | 36,13 | 34,92 | 35,42 | -0,99% | 3,33% | 18.421.115 |
| 19/02/2010 | 35,52 | 35,91 | 35,45 | 35,77 | +0,54% | 1,29% | 13.004.003 |
| 18/02/2010 | 35,57 | 35,78 | 35,33 | 35,58 | -0,13% | 1,26% | 12.942.590 |
| 17/02/2010 | 36,00 | 36,18 | 35,46 | 35,63 | -0,85% | 2,01% | 12.534.918 |
| 16/02/2010 | 35,99 | 36,43 | 35,55 | 35,94 | +2,00% | 2,44% | 21.768.951 |
| 12/02/2010 | 34,95 | 35,45 | 34,44 | 35,23 | +0,11% | 2,89% | 18.766.955 |
| 11/02/2010 | 34,56 | 35,31 | 34,23 | 35,19 | +1,88% | 3,12% | 15.123.478 |
| 10/02/2010 | 34,83 | 35,01 | 34,12 | 34,54 | -0,74% | 2,55% | 17.627.884 |
| 09/02/2010 | 35,24 | 35,47 | 34,66 | 34,80 | -0,33% | 2,30% | 17.965.864 |
| 08/02/2010 | 34,90 | 35,38 | 34,56 | 34,91 | -0,38% | 2,35% | 10.705.949 |
| 05/02/2010 | 35,35 | 35,38 | 34,18 | 35,05 | -1,00% | 3,40% | 24.074.970 |
| 04/02/2010 | 36,63 | 36,75 | 35,13 | 35,40 | -4,18% | 4,40% | 26.547.307 |
| 03/02/2010 | 37,60 | 37,61 | 36,71 | 36,95 | -2,07% | 2,41% | 18.305.311 |
| 02/02/2010 | 36,60 | 37,90 | 36,36 | 37,73 | +3,24% | 4,22% | 15.857.288 |
| 01/02/2010 | 36,79 | 36,86 | 36,33 | 36,55 | +0,31% | 1,45% | 9.666.647 |
| 29/01/2010 | 36,51 | 37,22 | 35,94 | 36,43 | +0,55% | 3,53% | 16.893.655 |
| 28/01/2010 | 36,97 | 37,16 | 36,20 | 36,23 | -1,73% | 2,58% | 14.008.197 |
| 27/01/2010 | 36,73 | 37,00 | 36,22 | 36,87 | +0,16% | 2,13% | 18.322.289 |
| 26/01/2010 | 36,74 | 37,17 | 36,41 | 36,81 | -0,46% | 2,05% | 20.817.158 |
| 25/01/2010 | 37,48 | 37,92 | 36,95 | 36,98 | -0,28% | 2,60% | 16.116.039 |
| 22/01/2010 | 38,07 | 38,44 | 36,99 | 37,09 | -3,02% | 3,81% | 18.301.853 |
| 21/01/2010 | 39,20 | 39,66 | 38,22 | 38,24 | -2,32% | 3,68% | 26.803.019 |
| 20/01/2010 | 38,78 | 39,27 | 38,14 | 39,15 | +1,01% | 2,90% | 21.843.150 |
| 19/01/2010 | 37,74 | 38,97 | 37,63 | 38,76 | +2,91% | 3,54% | 20.908.334 |
| 15/01/2010 | 38,15 | 38,43 | 37,22 | 37,66 | -1,30% | 3,15% | 21.854.258 |
| 14/01/2010 | 37,44 | 38,28 | 37,31 | 38,16 | +2,72% | 2,60% | 23.081.466 |